Emergent Health Corp. Updates Shareholders

KING OF PRUSSIA, Pa., Feb. 28, 2011 (GLOBE NEWSWIRE) -- Emergent Health Corp. (Pink Sheets:EMGE) (the "Company") is pleased to announce our securities have been approved to be traded by market makers as of February 2011. This means our stock is once again able to trade with "bids" and "asks" on the OTC Market, formerly known as Pink Sheets. We are excited about this development and hope it will renew confidence in shareholders that the Company is one with a long term vision for success with ongoing stock trading transparency intentions.

Our initial market maker is B.M.A. Securities (BMA). BMA is a FINRA member full service brokerage firm. BMA is located in Rolling Hill Estates, CA and offers a wide array of financial services. These include: market making, institutional trading, investment banking, advisory and consulting services.

We continue our efforts to increase both domestic and international sales. Our Physician Formulated Vita-Stim product promotes stem cell nutrition naturally. It was approved by the Cambodia Ministry of Health for resale the last quarter of 2010. Sales there, and in other parts of S.E. Asia, are in a developmental stage.

The Company's unaudited revenues for 2010 exceeded those of fiscal 2009 by almost 7% ($241,830 compared to $226,192). Pre-tax profits appear to be similar in the $40,000.00 range despite added expenses. Our comparable Balance Sheets for those years show continued improved strength in assets primarily through prudent cash management.

There is a video presentation of the Company and we invite you to view:

http://video214.com/play/YkqFsktfzOuT5RrzvYFY6g/s/dark

Those interested in distribution of our products in the USA may contact us below.

We wish to thank all of our shareholders for their patience and understanding.

About Emergent Health Corp.

Emergent Health Corp., a diversified biotechnology firm, is focused on the health and wellness industry. With patented and patent pending nutritionally designed products, Emergent believes it is positioning itself as a leader in the field of Regenerative Medicine as defined by the National Institute of Health.

Sign up for Free Newsletter Updates here:

http://emergenthealth.com

This press release contains certain "forward-looking" statements, defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates reflecting the company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by the company.

This press release is provided for information purposes only and is not intended to constitute an offer to sell or a solicitation of an offer to buy securities.

CONTACT: Emergent Health Corp.
         866-427-6143
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here